Viemed Healthcare (VMD) Total Debt Growth (1y) (2020 - 2026)
Viemed Healthcare (VMD) Total Debt Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 142.67% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | -9.88% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 1,188.16% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 0.12% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -17.79% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | -9.03% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | -0.50% |
| 10 | Viemed Healthcare | 331.59 Mn | 320.91 Mn | 45.05 Mn | 65.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 65.48% |
| Mar 31, 2026 | 134.82% |
| Dec 31, 2025 | 209.68% |
| Sep 30, 2025 | 373.76% |
| Jun 30, 2025 | -54.83% |
| Mar 31, 2025 | -39.71% |
| Dec 31, 2024 | -43.48% |
| Sep 30, 2024 | -55.06% |
| Jun 30, 2024 | -37.92% |
| Sep 30, 2023 | 129.78% |
| Jun 30, 2023 | 215.89% |
| Sep 30, 2022 | -30.90% |
| Jun 30, 2022 | -28.07% |
| Mar 31, 2022 | -25.99% |
| Dec 31, 2021 | -24.19% |
| Sep 30, 2021 | -22.57% |
| Jun 30, 2021 | -21.03% |
| Mar 31, 2021 | -19.77% |
| Dec 31, 2020 | -18.63% |
| Sep 30, 2020 | -17.63% |